Parent_Visium_Human_OvarianCancer - Whole transcriptome analysis, Adult Human Ovarian Cancer (Visium). Stains: Anti-Cytokeratin & Anti-CD45.

3,493
Number of Spots Under Tissue
80,586
Mean Reads per Spot
3,464
Median Genes per Spot

Sequencing

Number of Reads
Total number of read pairs that were assigned to this library in demultiplexing.
Valid Barcodes
Fraction of reads with barcodes that match the whitelist after barcode correction.
Valid UMIs
Fraction of reads with valid UMIs; i.e. UMI sequences that do not contain Ns and that are not homopolymers.
Sequencing Saturation
The fraction of reads originating from an already-observed UMI. This is a function of library complexity and sequencing depth. More specifically, this is the fraction of confidently mapped, valid spot-barcode, valid UMI reads that had a non-unique (spot-barcode, UMI, gene).
Q30 Bases in Barcode
Fraction of spot barcode bases with Q-score >= 30, excluding very low quality/no-call (Q <= 2) bases from the denominator.
Q30 Bases in RNA Read
Fraction of RNA read bases with Q-score >= 30, excluding very low quality/no-call (Q <= 2) bases from the denominator. This is Read 2 for the Visium v1 chemistry.
Q30 Bases in UMI
Fraction of UMI bases with Q-score >= 30, excluding very low quality/no-call (Q <= 2) bases from the denominator.
Number of Reads281,487,691
Valid Barcodes96.9%
Valid UMIs99.9%
Sequencing Saturation75.1%
Q30 Bases in Barcode96.6%
Q30 Bases in RNA Read95.3%
Q30 Bases in UMI96.5%

Mapping

Reads Mapped to Genome
Fraction of reads that mapped to the genome.
Reads Mapped Confidently to Genome
Fraction of reads that mapped uniquely to the genome. If a gene mapped to exonic loci from a single gene and also to non-exonic loci, it is considered uniquely mapped to one of the exonic loci.
Reads Mapped Confidently to Intergenic Regions
Fraction of reads that mapped uniquely to an intergenic region of the genome.
Reads Mapped Confidently to Intronic Regions
Fraction of reads that mapped uniquely to an intronic region of the genome.
Reads Mapped Confidently to Exonic Regions
Fraction of reads that mapped uniquely to an exonic region of the genome.
Reads Mapped Confidently to Transcriptome
Fraction of reads that mapped to a unique gene in the transcriptome. The read must be consistent with annotated splice junctions. These reads are considered for UMI counting.
Reads Mapped Antisense to Gene
Fraction of reads confidently mapped to the transcriptome, but on the opposite strand of their annotated gene. A read is counted as antisense if it has any alignments that are consistent with an exon of a transcript but antisense to it, and has no sense alignments.
Reads Mapped to Genome91.5%
Reads Mapped Confidently to Genome72.0%
Reads Mapped Confidently to Intergenic Regions5.2%
Reads Mapped Confidently to Intronic Regions9.7%
Reads Mapped Confidently to Exonic Regions57.1%
Reads Mapped Confidently to Transcriptome55.3%
Reads Mapped Antisense to Gene0.9%
 

Spots

Fraction Reads in Spots Under Tissue
The fraction of valid-barcode, confidently-mapped-to-transcriptome reads with tissue-associated barcodes.
Mean Reads per Spot
The number of reads, both under and outside of tissue, divided by the number of barcodes associated with a spot under tissue.
Mean Reads Under Tissue per Spot
The number of reads under tissue divided by the number of barcodes associated with a spot under tissue.
Median Genes per Spot
The median number of genes detected per spot under tissue-associated barcode. Detection is defined as the presence of at least 1 UMI count.
Total Genes Detected
The number of genes with at least one UMI count in any tissue covered spot.
Median UMI Counts per Spot
The median number of UMI counts per tissue covered spot.
Detected issue Image
Fraction Reads in Spots Under Tissue78.8%
Mean Reads per Spot80,586
Mean Reads Under Tissue per Spot60,870
Median Genes per Spot3,464
Total Genes Detected24,019
Median UMI Counts per Spot8,095

Sample

Sample IDParent_Visium_Human_OvarianCancer
Sample DescriptionWhole transcriptome analysis, Adult Human Ovarian Cancer (Visium). Stains: Anti-Cytokeratin & Anti-CD45.
ChemistrySpatial 3' v1
Slide Serial NumberV10A13-173-B1
Reference Path
‎/mnt/scratch2/spaceranger-1.2.0/refdata-gex-GRCh38-2020-A‎
TranscriptomeGRCh38-2020-A
Pipeline Versionspaceranger-1.2.0